Skip to main content
News Hörauf 08.2019
Histological section of Onchocerca volvulus, the cause of river blindness, under the microscope: Sections of a living female worm with offspring in the uteri. The symbiotic bacteria are stained in red
© Institute of Medical Microbiology, Immunology and Parasitology (IMMIP) / University Hospital Bonn

News categories: Honors & Funding

Bill and Melinda Gates Funding for Prof. Hörauf

More than 21 million people in Africa are infected with the nematode Onchocerca volvulus, the cause of river blindness. Around one in ten of those affected goes blind. Parasitologists around Prof. Hörauf at the University Hospital Bonn are looking for new, more effective weapons against the insidious parasite. The evaluation of the success of treatment is important. They now want to develop a method in which artificial intelligence (AI) automatically evaluates tissue samples from patients under the microscope. The aim is to reduce the time required and to establish an objective standard for analysis. The project is supported by the Bill & Melinda Gates Foundation.


Contact

Prof. Dr. med. Achim Hörauf

Medical Microbiology, Immunology and Parasitology

Medical Faculty

University of Bonn

University Hospital of Bonn

achim.hoerauf@ukb.uni-bonn.de

Related news

News Icon

News categories: Honors & Funding

Otto-Westphal Thesis Prize for Jonas Schulte-Schrepping

The German Society for Immunology e.V. (DGfI) anually honours one of its members by awarding the Otto-Westphal Thesis Prize. This year, Jonas Schulte-Schrepping from the research group of Prof. Joachim Schultze at the DZNE was selected for his PhD thesis on the systemic immune response to COVID-19. The prize is endowed with a prize money of 1,500 EUR.
View entry
DGORH Honours

News categories: Honors & Funding

Honours for research orthopaedic rheumatology

The German Society for Orthopaedic Rheumatology (DGORh) awards the Arthur Vick Prize annually. The award serves to promote research in the field of orthopaedic rheumatology. The prize is endowed with 7,000 euros.
View entry
News Icon

News categories: Honors & Funding

Acute lymphoblastic leukemia in children

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and poses a significant threat to health. The joint research project "EDI-4-ALL" (Early detection and interception for acute lymphoblastic leukemia) aims at the development of new analysis tools for the early detection of a genetic predisposition to ALL in newborns. The project is a joint endeavour by leading scientists from the Universities of Düsseldorf, Gießen and Bonn, the Charité Berlin and Zytovision, under participation of Prof. Alksandra Pandyra. The project is funded with a total of 2.6 million Euros by the BMBF.
View entry

Back to the news overview